Natural Killer Cell with Glowing CD25 Receptors Attacking Cancer Cell

Unlocking NK Cell Potential: Can CD25 Be the Key to Enhanced Immunity?

Author's portrait.
Lena Voss in Health & Wellness August 2025 • 5 min read.

"New Research Reveals a Promising Link Between CD25 Expression and Natural Killer Cell Cytotoxic Activity, Opening Doors to Innovative Immunotherapies."


Natural killer (NK) cells are a vital component of the immune system, acting as front-line defenders against infections and cancer. Unlike T and B cells, NK cells don't require prior sensitization to recognize and eliminate threats, making them crucial for rapid immune responses. Scientists have long sought ways to boost NK cell activity to improve the body's ability to fight disease.

Cytotoxic activity, or the ability to directly kill infected or cancerous cells, is one of the primary functions of NK cells. Researchers employ various assays to measure this activity, but a simple, receptor-based marker that could easily identify highly cytotoxic NK cells has remained elusive. This is where the CD25 receptor comes into play.

A recent study investigated the potential of CD25, also known as the interleukin-2 receptor (IL-2R), as a marker for NK cell cytotoxic activity. The research, led by Karolina Rudnicka and colleagues, explored the correlation between CD25 expression on NK cells and their ability to target and eliminate cancer cells. Their findings suggest that CD25 could indeed serve as a valuable tool for identifying and potentially enhancing NK cell function.

How Does CD25 Expression Relate to NK Cell Cytotoxicity?

Natural Killer Cell with Glowing CD25 Receptors Attacking Cancer Cell

The study, published in Acta Biochimica Polonica, detailed the experimental approach used to investigate the link between CD25 and NK cell activity. Researchers isolated lymphocytes from healthy volunteers and stimulated them with lipopolysaccharide (LPS), a component of bacterial cell walls known to activate immune cells. These stimulated lymphocytes were then co-cultured with HeLa cells, a common cancer cell line, in a cytotoxic assay.

The cytotoxic effect of the NK cells was evaluated using several methods, including: MTT reduction assay: Measures the metabolic activity of viable cells, providing an indication of cell survival. ELISA: Used to quantify the levels of various cytokines and cytotoxic markers released by the NK cells, such as granzyme B, FasL, caspase-8, IFN-γ, and IL-2. Flow cytometry: A technique used to identify and quantify cells based on the expression of specific surface markers, in this case, CD3, CD56/CD16/NKp46, and CD25.

MTT reduction assay: Measures the metabolic activity of viable cells, providing an indication of cell survival. ELISA: Used to quantify the levels of various cytokines and cytotoxic markers released by the NK cells, such as granzyme B, FasL, caspase-8, IFN-γ, and IL-2. Flow cytometry: A technique used to identify and quantify cells based on the expression of specific surface markers, in this case, CD3, CD56/CD16/NKp46, and CD25.
The researchers observed a significant positive correlation between CD25 expression on CD3-CD56+ NK cells and several indicators of cytotoxic function. Specifically, they found that NK cells expressing CD25 exhibited: Enhanced cytotoxic activity in the MTT assay. Increased production of granzyme B, a key enzyme involved in inducing target cell death. Elevated levels of IL-2 and IFN-γ, cytokines that play important roles in immune regulation and NK cell activation. Interestingly, CD25 expression was not correlated with the levels of FasL and caspase-8, suggesting that NK cells might be using different pathways to induce cell death in this setting.

The Significance of CD25 in NK Cell Research

These findings suggest that CD25 expression could serve as a valuable in vitro marker for screening and identifying NK cells with high cytotoxic potential. This could have significant implications for developing new immunotherapies, particularly in cancer treatment, where enhancing NK cell activity is a major goal. By using CD25 as a marker, researchers could potentially select and expand highly cytotoxic NK cells for adoptive cell therapy, a strategy that involves transferring immune cells into a patient to fight disease.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What are natural killer cells and why are they important?

Natural killer cells, or NK cells, are a type of immune cell that is critical for the body's rapid response to infections and cancer. They are different from T and B cells because they can recognize and eliminate threats without needing prior sensitization. This makes them vital for immediate immune defense.

2

What does cytotoxic activity mean in the context of natural killer cells?

Cytotoxic activity refers to the ability of NK cells to directly kill infected or cancerous cells. This is a primary function of NK cells and is crucial for controlling the spread of disease. Scientists have been looking for ways to easily identify NK cells with high cytotoxic activity, which brings us to CD25.

3

What is CD25 and how does it relate to natural killer cells?

CD25, also known as the interleukin-2 receptor (IL-2R), is a receptor found on the surface of some NK cells. Research suggests that CD25 could be a marker for identifying NK cells with high cytotoxic potential. This means that NK cells expressing CD25 are more likely to be effective at killing infected or cancerous cells.

4

How was the cytotoxic activity of NK cells measured in the study?

The study used several methods to evaluate the cytotoxic effect of NK cells. These include the MTT reduction assay, which measures the metabolic activity of viable cells; ELISA, which quantifies the levels of cytokines and cytotoxic markers released by NK cells, such as granzyme B, FasL, caspase-8, IFN-γ, and IL-2; and flow cytometry, which identifies and quantifies cells based on the expression of specific surface markers, including CD3, CD56/CD16/NKp46, and CD25.

5

What is the significance of the findings regarding CD25 and NK cell research?

The findings suggest that CD25 can be used as a marker to identify highly cytotoxic NK cells. This is significant for developing new immunotherapies, especially in cancer treatment. By selecting and expanding CD25-expressing NK cells, researchers could potentially enhance the effectiveness of adoptive cell therapy, where immune cells are transferred into a patient to fight disease. The study did not explore other markers or combinations of markers that might further refine the identification of highly active NK cell subsets. Further research could also investigate the stability and regulation of CD25 expression on NK cells in different disease contexts.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.